Additionally, suppressing IFN signaling through neutralizing antibodies to the interferon-alpha and -beta receptor subunit 1 (IFNAR1) was effective in significantly delaying T1D onset [127,128]. This evidence concerns the gene IFNA1 and type 1 diabetes mellitus.